North Control BIO Growth Technology (08247.HK) released its interim financial results, with shareholders' loss of 17.976 million yuan, an increase of 36.37% compared to the same period last year.

Zhongsheng Beikong Biotechnology (08247.HK) announced its interim results for the six months ending on June 30, 2025 on the Zhitrust Financial APP. The group's operating income was 95.815 million yuan, a decrease of 28.4% year-on-year; the shareholders' net loss was 17.976 million yuan, an increase of 36.37% year-on-year; and the loss per share was 0.124 yuan.